During the past decade, Charité Campus Mitte, Med.Klinik, Rheumatologie und Klinische Immunologie conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Charité Campus Mitte, Med.Klinik, Rheumatologie und Klinische Immunologie" are "Rheumatoid Arthritis" (4 trials), "Giant Cell Arteritis" (1 trials), "Lupus Nephritis" (1 trials), "Polymyalgia Rheumatica" (1 trials) and "Systemic Sclerosis" (1 trials). Many other conditions were trialed in "Charité Campus Mitte, Med.Klinik, Rheumatologie und Klinische Immunologie" in a lesser frequency.

Most popular intervention types in "Charité Campus Mitte, Med.Klinik, Rheumatologie und Klinische Immunologie" are "Drug" (8 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Tocilizumab" (4 trials), "Prednisone" (3 trials), "Methotrexate" (2 trials), "Acetaminophen" (1 trials) and "Additional prednisolone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Charité Campus Mitte, Med.Klinik, Rheumatologie und Klinische Immunologie" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Charité Campus Mitte, Med.Klinik, Rheumatologie und Klinische Immunologie". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Charité Campus Mitte, Med.Klinik, Rheumatologie und Klinische Immunologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Charité Campus Mitte, Med.Klinik, Rheumatologie und Klinische Immunologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".